Emergency use of the anti-malaria drug hydroxychloroquine as a treatment for coronavirus has been withdrawn by the US Food and Drug Administration (FDA). The FDA said that new evidence from clinical trials meant that it was no longer reasonable to believe that the drug would produce an antiviral effect. President Donald Trump later defended promoting the use of hydroxychloroquine as a treatment of Covid-19. In March, the FDA granted the emergency use of the drug for some serious cases.
- Importation of handloom and batik textiles suspended
- Rugby chiefs at odds over rescheduling 2020 after World Rugby meeting